News
-
Folic acid & psychosis
Friday | Jul 6 2018WHILE we knew consuming more folic acid during pregnancy reduces neural tube defects, a study from the US has confirmed another benefit of fortifying bread with folic acid: protection against psychosis.
-
Mening B vax for SA
Friday | Jul 6 2018SOUTH Australia will be the first jurisdiction in Australia to introduce a vaccination program for babies and young people against the potentially deadly meningococcal B disease.
-
Q-Pharm expands research capacity
Friday | Jul 6 2018Q-PHARM has grown its capacity for research with the opening of the newly expanded Q-Pharm Pty Ltd premises in Queensalnd.
-
Chemo co-pay gone
Friday | Jul 6 2018ACT cancer patients will receive more financial support during their chemotherapy treatments, with the ACT Government announcing it will meet the cost of chemotherapy medication co-payments.
-
AusCann raises $33.4m
Friday | Jul 6 2018LISTED pharmaceutical cannabis company AusCann has announced it has raised $33.4 million via a share placement to institutional and sophisticated investors from North America and Australia.
-
The key to diabetes
Friday | Jul 6 2018DIABETICS across Australia are struggling to source their essential keytone urine-testing strips, which are being purchased in bulk by ketogenic dieters, the ABC reports.
-
Dispensary Corner
Friday | Jul 6 2018
06 Jul 18PUMP it up - a man with what may be an unusual fetish, or a very good Ebay account, was observed on CCTV helping himself to several breast pumps worth $1,100, reports the Gold Coast Bulletin.
-
Travel Specials 05 July 18
Thursday | Jul 5 201815% OFF Peregrine Adventures Asia Cruises: Peregrine invites you to visit the pristine islands, hidden waterfalls.
-
Hospital meds transitions
Thursday | Jul 5 2018MINISTER for Health Greg Hunt has announced 15 new projects utilising data from consenting patients' My Health Record (MHR) to improve the delivery of their healthcare, some with a focus on transitioning from hospital to community pharmacy.
-
Cannabis for cancer pain
Thursday | Jul 5 2018ASX-LISTED medical life sciences company Medlab Clinical reports that its clinical trial of its cannabis-based medicine, NanaBis, is on schedule with recruitment.
